Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Antigène CD20")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2350

  • Page / 94
Export

Selection :

  • and

Does rituximab aggravate pre-existing hypogammaglobulinaemia?DIWAKAR, Lavanya; GORRIE, Sheryl; RICHTER, Alex et al.Journal of clinical pathology. 2010, Vol 63, Num 3, pp 275-277, issn 0021-9746, 3 p.Article

Update on rituximabEISENBERG, R.Annals of the rheumatic diseases. 2005, Vol 64, pp iv55-iv57, issn 0003-4967, SUP4Conference Paper

Development of novel humanized anti-CD20 antibodies based on affinity constant and epitopeUCHIYAMA, Susumu; SUZUKI, Yasuhiko; FUKUI, Kiichi et al.Cancer science. 2010, Vol 101, Num 1, pp 201-209, issn 1347-9032, 9 p.Article

Mechanism of impaired immunologic response to bacterial antigens in burn wounds in childrenANDRZEJEWSKA, E; NIEWIADOMSKA, H; NAWROT, E et al.Pediatric surgery international. 2000, Vol 16, Num 1-2, pp 85-88, issn 0179-0358Article

Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodiesNIEDERFELLNER, Gerhard; LAMMENS, Alfred; TIMMERMAN, Peter et al.Blood. 2011, Vol 118, Num 2, pp 358-367, issn 0006-4971, 10 p.Article

Rituximab : Applications in dermatologyFATOURECHI, Mitra M; EL-AZHARY, Rokea A; GIBSON, Lawrence E et al.International journal of dermatology. 2006, Vol 45, Num 10, pp 1143-1155, issn 0011-9059, 13 p.Article

Lineage determination of CD20- B-cell neoplasms : An immunohistochemical studyCHU, Peiguo G; LOERA, Sofia; QIN HUANG et al.American journal of clinical pathology. 2006, Vol 126, Num 4, pp 534-544, issn 0002-9173, 11 p.Article

Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugatesLAW, Che-Leung; CERVENY, Charles G; SENTER, Peter D et al.Clinical cancer research. 2004, Vol 10, Num 23, pp 7842-7851, issn 1078-0432, 10 p.Article

CD20-Targeted Therapy: The Next Generation of AntibodiesVAN MEERTEN, Tom; HAGENBEEK, Anton.Seminars in hematology. 2010, Vol 47, Num 2, pp 199-210, issn 0037-1963, 12 p.Article

Place des anticorps monoclonaux (anti-CD52, anti-CD20) dans la leucémie lymphoïde chroniqueDIVINE, Marine.Hématologie (Montrouge). 2006, Vol 12, pp 35-38, issn 1264-7527, 4 p., NS6Article

Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disordersLEVESQUE, M. C.Clinical and experimental immunology (Print). 2009, Vol 157, Num 2, pp 198-208, issn 0009-9104, 11 p.Article

Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137LBODOGAI, Monica; CHANG, Catalina Lee; WEJKSZA, Katarzyna et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 7, pp 2127-2138, issn 0008-5472, 12 p.Article

Mott cells in CD20-positive myelomaRAMASAMY, Karthik; LADON, Dariusz; SALISBURY, Jon et al.British journal of haematology. 2011, Vol 152, Num 4, issn 0007-1048, p. 366Article

CD20 as a Target for Therapeutic Type I and II Monoclonal AntibodiesBEERS, Stephen A; CHAN, Claude H. T; FRENCH, Ruth R et al.Seminars in hematology. 2010, Vol 47, Num 2, pp 107-114, issn 0037-1963, 8 p.Article

Rituximab in Lymphocyte-Predominant Hodgkin DiseaseAZIM, Hatem A; PRUNERI, Giancarlo; COCOROCCHIO, Emilia et al.Oncology. 2009, Vol 76, Num 1, pp 26-29, issn 0030-2414, 4 p.Article

Anticorps monoclonaux thérapeutiques en oncohématologie = Therapeutic monoclonal antibodies in onco-hematologyCARTRON, Guillaume; ROSSI, Jean-François.MS. Médecine sciences. 2009, Vol 25, Num 12, pp 1085-1089, issn 0767-0974, 5 p.Article

Six refractory lupus patients treated with rituximab : A case seriesZELL GILLIS, Joann; DALL'ERA, Maria; GROSS, Andrew et al.Arthritis care and research. 2007, Vol 57, Num 3, pp 538-542, issn 0893-7524, 5 p.Article

A high throughput electrochemiluminescent cell-binding assay for therapeutic anti-CD20 antibody selectionYANMEI LU; WONG, Wai Lee; MENG, Y. Gloria et al.Journal of immunological methods. 2006, Vol 314, Num 1-2, pp 74-79, issn 0022-1759, 6 p.Article

Rituximab in the treatment of antisynthetase syndromeBRULHART, L; WALDBURGER, J.-M; GABAY, C et al.Annals of the rheumatic diseases. 2006, Vol 65, Num 7, pp 974-975, issn 0003-4967, 2 p.Article

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesGOTTENBERG, J.-E; GUILLEVIN, L; FAIN, O et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 6, pp 913-920, issn 0003-4967, 8 p.Article

CD20 positive T cell lymphoma: is it a real entity?SUN, T; AKALIN, A; RODACKER, M et al.Journal of clinical pathology. 2004, Vol 57, Num 4, pp 442-444, issn 0021-9746, 3 p.Article

Pretreatment with rituximab does not inhibit the human immune response against the immunogenic protein LMB-1HASSAN, Raffit; WILLIAMS-GOULD, Juanita; WATSON, Thelma et al.Clinical cancer research. 2004, Vol 10, Num 1, pp 16-18, issn 1078-0432, 3 p., 1Article

Anticorps monoclonal anti-CD20 et traitement des maladies auto-immunes = Rituximab and auto-immune disorders therapyQUINT, L.La Revue de médecine interne (Paris). 2004, Vol 25, Num 10, pp 752-754, issn 0248-8663, 3 p.Article

Clearing minimal residual disease with rituximab consolidation therapyBRUGGER, Wolfram.Seminars in oncology. 2004, Vol 31, pp 33-37, issn 0093-7754, 5 p., SUP2Article

Utilisation du rituximab dans les maladies auto-immunes en pédiatrieRevue du rhumatisme (Ed. française). 2013, Vol 80, pp 23-31, issn 1169-8330, 9 p., HS1Article

  • Page / 94